GGrantIndex
Sort

46,585 grants matching heart failure

2/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension-DCC

$562,043
Hrishikesh Chakraborty · Duke University · U24 · FY2025 · HL

Bioengineering Analysis of Muscle Mechanics & Metabolism

$562,032
Srboljub M Mijailovich · Harvard School Of Public Health · R01 · FY2006 · AR

Hydrogen Sulfide Regulation in Cardioprotection

$561,962
Ming Xian · Brown University · R01 · FY2022 · HL

Novel Role of Bscl2 in Cardiac Substrate Metabolism and Function

$561,866
Weiqin Chen · Augusta University · R01 · FY2023 · HL

Improving outcomes from cardiac rehabilitation among older adults through exercise testing and individualized exercise intensity prescriptions

$561,824
Quinn Russell Pack · Baystate Medical Center, Inc. · R01 · FY2025 · AG

Receptor-regulated Ca2+ entry pathways in smooth muscle

$561,816
Mohamed Trebak · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2017 · HL

Receptor-regulated Ca2+ entry pathways in smooth muscle

$561,816
Mohamed Trebak · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2018 · HL

SK current and ventricular arrhythmias.

$561,784
Peng-Sheng Chen · Cedars-Sinai Medical Center · R01 · FY2021 · HL

2/2: Pediatric Prehospital Airway Resuscitation Trial (Pedi-PART)

$561,767
John Vanburen · University Of Utah · U24 · FY2023 · HL

Physiologic Profiling of sGC Genetic Variants

$561,737
Christopher Holmes Newton-Cheh · Massachusetts General Hospital · R01 · FY2015 · HL

CIND: Risk Factors for Conversion to Dementia

$561,697
Frederick W. Unverzagt · Indiana University Indianapolis · R01 · FY2008 · AG

Abnormal intracellular calcium release in heart failure

$561,669
Sandor Gyorke · Ohio State University · R01 · FY2021 · HL

Regulation of TRPM7 Channels

$561,646
Loren W Runnels · Rbhs-Robert Wood Johnson Medical School · R01 · FY2019 · HL

The Role of E-cigarette Characteristics and Constituents in Cardiac Dysfunction

$561,625
Alex Perrow Carll · University Of Louisville · R01 · FY2021 · HL

Transition of Care in CKD (TC-CKD)

$561,587
Kamyar Kalantar-Zadeh · University Of California-Irvine · U01 · FY2016 · DK

Improving Glycemic Management in Patients with Type 1 Diabetes Using a Context-aware Automated Insulin Delivery System

$561,582
Peter G Jacobs · Oregon Health & Science University · R01 · FY2021 · DK

Heart Failure in the Community

$561,543
Mayo Clinic · R01 · FY2004 · HL

Gene Therapy for Long-Term Myocardial Protection

$561,542
Victor J Dzau · Duke University · R01 · FY2011 · HL

Development and validation of cardiovascular MRI techniques on a low-field, ultra-wide bore system to assess patients with severe obesity

$561,465
Orlando Paul Simonetti · Ohio State University · R01 · FY2025 · HL

Deciphering the role of Lmod2 in cardiac muscle and in dilatedcardiomyopathy

$561,421
Carol C Gregorio · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL

Deciphering the role of Lmod2 in cardiac muscle and in dilated cardiomyopathy

$561,421
Carol C Gregorio · University Of Arizona · R01 · FY2022 · HL

RNA methylation in the progress of heart failure

$561,392
Suresh K Verma · University Of Alabama At Birmingham · R01 · FY2025 · HL

Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1

$561,360
Robin Mark Shaw · University Of Utah · R01 · FY2023 · HL

Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1

$561,360
Robin Mark Shaw · University Of Utah · R01 · FY2022 · HL

The Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC)

$561,279
Monica Kraft · University Of Arizona · U19 · FY2020 · AI